For: | Farinati F, Cardin R, Bortolami M, Guido M, Rugge M. Oxidative damage, pro-inflammatory cytokines, TGF-α and c-myc in chronic HCV-related hepatitis and cirrhosis. World J Gastroenterol 2006; 12(13): 2065-2069 [PMID: 16610058 DOI: 10.3748/wjg.v12.i13.2065] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v12/i13/2065.htm |
Number | Citing Articles |
1 |
Cardin Romilda, Piciocchi Marika, Sinigaglia Alessandro, Lavezzo Enrico, Bortolami Marina, Kotsafti Andromachi, Cillo Umberto, Zanus Giacomo, Mescoli Claudia, Rugge Massimo, Farinati Fabio. Oxidative DNA damage correlates with cell immortalization and mir-92 expression in hepatocellular carcinoma. BMC Cancer 2012; 12(1) doi: 10.1186/1471-2407-12-177
|
2 |
Romilda Cardin, Marika Piciocchi, Diego Martines, Laura Scribano, Marino Petracco, Fabio Farinati. Effects of coffee consumption in chronic hepatitis C: A randomized controlled trial. Digestive and Liver Disease 2013; 45(6): 499 doi: 10.1016/j.dld.2012.10.021
|
3 |
Naohiro Hosomura, Hiroshi Kono, Masato Tsuchiya, Kenichi Ishii, Masahito Ogiku, Masanori Matsuda, Hideki Fujii. HCV-Related Proteins Activate Kupffer Cells Isolated from Human Liver Tissues. Digestive Diseases and Sciences 2011; 56(4): 1057 doi: 10.1007/s10620-010-1395-y
|
4 |
Caterina Clemente, Silvana Elba, Gianpiero Buongiorno, Vito Guerra, Benedetta D'Attoma, Antonella Orlando, Francesco Russo. Manganese superoxide dismutase activity and incidence of hepatocellular carcinoma in patients with Child–Pugh class A liver cirrhosis: a 7‐year follow‐up study. Liver International 2007; 27(6): 791 doi: 10.1111/j.1478-3231.2007.01485.x
|
5 |
Maha H. Sharawy, Noha Abdel-Rahman, Nirmeen Megahed, Mohammed S. El-Awady. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: Role of TGF-β1, IL-10 and c-Myc. Life Sciences 2018; 211: 245 doi: 10.1016/j.lfs.2018.09.037
|
6 |
Masao Honda, Kenji Takehana, Akito Sakai, Yusuke Tagata, Takayoshi Shirasaki, Shinobu Nishitani, Takahiko Muramatsu, Tatsuya Yamashita, Yasunari Nakamoto, Eishiro Mizukoshi, Yoshio Sakai, Taro Yamashita, Mikiko Nakamura, Tetsuro Shimakami, MinKyung Yi, Stanley M. Lemon, Tetsuo Suzuki, Takaji Wakita, Shuichi Kaneko. Malnutrition Impairs Interferon Signaling Through mTOR and FoxO Pathways in Patients With Chronic Hepatitis C. Gastroenterology 2011; 141(1): 128 doi: 10.1053/j.gastro.2011.03.051
|
7 |
Manuela G. Neuman, Kevin Sha, Rustan Esguerra, Sam Zakhari, Robert E. Winkler, Nir Hilzenrat, Jonathan Wyse, Curtis L. Cooper, Devanshi Seth, Mark D. Gorrell, Paul S. Haber, Geoffrey W. McCaughan, Maria A. Leo, Charles S. Lieber, Mihai Voiculescu, Eugenia Buzatu, Camelia Ionescu, Jozsef Dudas, Bernhard Saile, Giuliano Ramadori. Inflammation and Repair in Viral Hepatitis C. Digestive Diseases and Sciences 2008; 53(6) doi: 10.1007/s10620-007-0047-3
|
8 |
Howard E. Boudreau, Suzanne U. Emerson, Agnieszka Korzeniowska, Meghan A. Jendrysik, Thomas L. Leto. Hepatitis C Virus (HCV) Proteins Induce NADPH Oxidase 4 Expression in a Transforming Growth Factor β-Dependent Manner: a New Contributor to HCV-Induced Oxidative Stress. Journal of Virology 2009; 83(24): 12934 doi: 10.1128/JVI.01059-09
|
9 |
F. Farinati, R. Cardin, M. Bortolami, P. Burra, F. P. Russo, M. Rugge, M. Guido, A. Sergio, R. Naccarato. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. Journal of Viral Hepatitis 2007; 14(12): 821 doi: 10.1111/j.1365-2893.2007.00878.x
|
10 |
Manuela G. Neuman, Kristi K. McKinney, Radu M. Nanau, Vincent Kong, Izabella Malkiewicz, Tony Mazulli, George Moussa, Lawrence B. Cohen. Drug-induced severe adverse reaction enhanced by human herpes virus-6 reactivation. Translational Research 2013; 161(5): 430 doi: 10.1016/j.trsl.2012.12.012
|
11 |
Marika Piciocchi, Romilda Cardin, Alessandro Vitale, Veronica Vanin, Anna Giacomin, Caterina Pozzan, Gemma Maddalo, Umberto Cillo, Maria Guido, Fabio Farinati. Circulating free DNA in the progression of liver damage to hepatocellular carcinoma. Hepatology International 2013; 7(4): 1050 doi: 10.1007/s12072-013-9481-9
|
12 |
Barbara Roe, William W. Hall. Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus. Expert Reviews in Molecular Medicine 2008; 10 doi: 10.1017/S1462399408000847
|
13 |
Amy Thomas, Carl Laxton, Joanne Rodman, Nisha Myangar, Nigel Horscroft, Tanya Parkinson. Investigating Toll-Like Receptor Agonists for Potential To Treat Hepatitis C Virus Infection. Antimicrobial Agents and Chemotherapy 2007; 51(8): 2969 doi: 10.1128/AAC.00268-07
|
14 |
Arpit Bhargava, Gorantla V. Raghuram, Neelam Pathak, Subodh Varshney, Suresh K. Jatawa, Deepika Jain, Pradyumna K. Mishra. Occult hepatitis C virus elicits mitochondrial oxidative stress in lymphocytes and triggers PI3-kinase-mediated DNA damage response. Free Radical Biology and Medicine 2011; 51(9): 1806 doi: 10.1016/j.freeradbiomed.2011.08.009
|
15 |
Manuela G. Neuman, Hemda Schmilovitz-Weiss, Nir Hilzenrat, Marc Bourliere, Patrick Marcellin, Cristhian Trepo, Tony Mazulli, George Moussa, Ankit Patel, Asad A. Baig, Lawrence Cohen. Markers of Inflammation and Fibrosis in Alcoholic Hepatitis and Viral Hepatitis C. International Journal of Hepatology 2012; 2012: 1 doi: 10.1155/2012/231210
|
16 |
Rabia Nawaz, Sadia Zahid, Muhammad Idrees, Shazia Rafique, Muhammad Shahid, Ammara Ahad, Iram Amin, Iqra Almas, Samia Afzal. HCV-induced regulatory alterations of IL-1β, IL-6, TNF-α, and IFN-ϒ operative, leading liver en-route to non-alcoholic steatohepatitis. Inflammation Research 2017; 66(6): 477 doi: 10.1007/s00011-017-1029-3
|
17 |
Mohammed Asmal, Michael Seaman, Wenyu Lin, Raymond T Chung, Norman L Letvin, Ralf Geiben-Lynn. Inhibition of HCV by the serpin antithrombin III. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-226
|
18 |
Mohamed El-Shahat Ebeid, Kadry Abdel-Kader El-Bakry. Cellular immune response to infection by different genotypes of hepatitis C virus. Indian Journal of Clinical Biochemistry 2009; 24(3): 234 doi: 10.1007/s12291-009-0044-8
|
19 |
Marina Bortolami, Romilda Cardin, Andromachi Kotsafti, Fabio Farinati. TGF-β and hepatocellular carcinoma. Hepatology 2008; 47(3): 1095 doi: 10.1002/hep.22156
|
20 |
Satheesh K. Sainathan, Kumar S. Bishnupuri, Konrad Aden, Qizhi Luo, Courtney W. Houchen, Shrikant Anant, Brian K. Dieckgraefe. Toll-like receptor-7 ligand imiquimod induces type I interferon and antimicrobial peptides to ameliorate dextran sodium sulfate-induced acute colitis. Inflammatory Bowel Diseases 2012; 18(5): 955 doi: 10.1002/ibd.21867
|
21 |
Ijaz S Jamall, Shafaq Yusuf, Maimoona Azhar, Selene Jamall. Is pegylated interferon superior to interferon, with ribavarin, in chronic hepatitis C genotypes 2/3?. World Journal of Gastroenterology 2008; 14(43): 6627-6631 doi: 10.3748/wjg.14.6627
|
22 |
Ali Sepehrinezhad, Ali Shahbazi. Liver Cirrhosis and Its Complications - Advances in Diagnosis and Management. 2024; doi: 10.5772/intechopen.1004125
|
23 |
Shereen M. Shawki, Safa S. Meshaal, Aliaa S. El Dash, Naglaa A. Zayed, Mariam Onsy F. Hanna. Increased DNA Damage in Hepatitis C Virus-Related Hepatocellular Carcinoma. DNA and Cell Biology 2014; 33(12): 884 doi: 10.1089/dna.2014.2417
|